August 9 VC News Roundup: Agentic Security, Voice CX, Edge Compute & Trial AI
Gap-fill investment news for Aug 9: Index→Intelligence, BCV→Straiker, Omilia, Encore, Smallest.ai, QuantHealth, and Acrab — who uses the products and why these funds fit.
Earlier August batches already covered Hadrian, HappyRobot, Moove, Convex, Fireworks, and the Bessemer cyber cluster. This roundup is the gap-fill — seven deals that still needed VCT-style write-ups: who uses the product, why now, and why this capital.
Snapshot table
| Company | Amount | Stage | Key capital | Job |
|---|---|---|---|---|
| Acrab | $130M | Series B | Vertex SEA & Growth | On-device agentic compute |
| Omilia | $67M | Series B | Expedition Growth | Voice-first agentic CX |
| Straiker | $64M | Series A | Marathon + BCV | Agentic security |
| QuantHealth | $45M | Series B | Qumra + Sanofi Ventures | Trial simulation before FPI |
| Encore AI | $30M | Series A | Team8 + customer banks | Revenue agents in FS |
| Smallest.ai | $13M | Series A | Seligman | Real-time voice infra |
| Intelligence | $7.9M | Seed | Index Ventures | Human taste evals for visual AI |
Theme 1 — Agents need a security and eval layer
Straiker treats agents like employees with keys: discover → adversarially test → runtime protect. Bain Capital Ventures returning next to Workday and Citi Ventures is the enterprise distribution tell.
Intelligence / Design Arena sells the other scarce input: human taste for visual models. Index Ventures leading a $7.9M seed (with a company-reported ARR claim — treat carefully) puts preference data next to model infra.
Theme 2 — Voice is splitting into CX apps vs voice infra
Omilia shows capital-efficient CX: >$60M ARR, $67M B, owned models, zero token pass-through — Capital One to Taco Bell.
Encore AI flips the KPI from deflection to revenue (conversion, collections) and put customer banks on the cap table.
Smallest.ai sells the latency layer those apps need — async Hydra architecture so conversations do not wait on a full LLM turn.
Theme 3 — Physical and clinical systems still eat capital
Acrab ($130M) is Vertex doubling down on Singapore edge silicon + agent software for industrial deployments.
QuantHealth ($45M) simulates trials before enrollment — Qumra-led with Sanofi Ventures, aimed at the ~90% clinical failure tax.
How to use these pages
| Audience | Start here |
|---|---|
| Founders (agents) | Straiker + Intelligence — security and eval are becoming mandatory companions |
| Founders (voice) | Omilia vs Smallest.ai — decide if you are the app or the infra |
| Investors / scouts | Follow /fund/index-ventures and /fund/bain-capital-ventures for directory-linked deals |
| Operators | Omilia/Encore for production CX KPIs; QuantHealth if you buy clinical development tools |
Browse more funds in the directory.
Sources
Primary links live on each deep-dive. Roundup anchors:
- https://techcrunch.com/2026/08/03/designarena-creators-raise-7-9-million-to-bring-taste-to-ai-models/
- https://omilia.com/resources/news/omilia-secures-67-million-in-series-b-funding-to-accelerate-global-expansion-of-its-agentic-cx-platform-for-large-enterprises/
- https://www.prnewswire.com/news-releases/acrab-raises-us130-million-series-b-advancing-agentic-ai-compute-platform-commercialization-302844535.html
- https://www.straiker.ai/blog/straiker-raises-64m-series-a-to-secure-the-agentic-workforce
Follow Venture Capital Tracker in Google
Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
